BioCryst Pharmaceuticals BCRX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's prepaid & other current?
- BioCryst Pharmaceuticals (BCRX) reported prepaid & other current of $19.11M in Q1 2026.
- How has BioCryst Pharmaceuticals's prepaid & other current changed year-over-year?
- BioCryst Pharmaceuticals's prepaid & other current increased by 33.4% year-over-year, from $14.33M to $19.11M.
- What is the long-term trend for BioCryst Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's prepaid & other current has grown at a 25.5% compound annual growth rate (CAGR), from $5.53M to $17.18M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.